Butane

Butane

SCHEMBL6289475

CCCC.O=C(O)Oc1ccccc1Oc1ccccc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
POLB P06746 2/20 0.50
ATM Q13315 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
LMNA P02545 2/20 0.49
MAPT P10636 1/20 0.49
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
TSPO P30536 1/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
MTNR1B P49286 1/20 0.46
TTR P02766 1/20 0.45
RAB9A P51151 1/20 0.44
ADRA2C P18825 1/20 0.44
HTT P42858 1/20 0.44
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL571709 0.91 CTNNB1 (0.55) CTNNB1L3MBTL1LMNAALDH1A1TSHR
Butane SCHEMBL1395551 0.89 KDM4E (0.47) L3MBTL1POLBLMNAALDH1A1TSHR
SCHEMBL16319105 0.83 CTNNB1 (0.47) CTNNB1L3MBTL1LMNAMAPTALDH1A1
SCHEMBL1345670 0.82 ELANE (0.51) CTNNB1L3MBTL1POLBATMNPSR1
SCHEMBL16319433 0.80 HTT (0.48) CTNNB1LMNAMAPTALDH1A1TSHR
Butane SCHEMBL1960365 0.79 KDM4E (0.44) L3MBTL1POLBLMNAMAPTALDH1A1
SCHEMBL6690457 0.79 KDM4E (0.58) CTNNB1L3MBTL1POLBLMNAMAPT
SCHEMBL11881421 0.79 CTNNB1 (0.55) CTNNB1L3MBTL1LMNAALDH1A1TSHR
SCHEMBL4619100 0.79 KMT2A (0.46) CTNNB1POLBLMNAALDH1A1KMT2A
SCHEMBL27614522 0.79 CTNNB1 (0.61) CTNNB1L3MBTL1ATMNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6867200-B1 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-15 US disclosed
EP-1140859-A2 (HETERO)ARYL-BICYCLIC HETEROARYL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-10-10 EP disclosed
WO-2000035886-A2 (HETERO)ARYL-BICYCLIC HETEROARYL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-06-22 WO disclosed